Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)

✍ Scribed by Antoaneta Tomova; Rupert Bartsch; Thomas Brodowicz; Valentina Tzekova; Constanta Timcheva; Christoph Wiltschke; Dany Abi Gerges; Jan Pawlega; Stanislav Spanik; Moshe Inbar; Christoph C. Zielinski

• Publisher: Springer US
• Year: 2009
• Tongue: English
• Weight: 277 KB
• Volume: 119
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-009-0553-4